Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The shared biological properties of exendin-4 and human GLP-1 probably stem from their primary and secondary structures, but exendin-4 is naturally resistant to degradation by the DPP-4 enzyme, attributed to the presence of glycine at position 2, resulting in an intravenous half-life of approximately 30 minutes (85)
This highlights that obesity is a chronic condition, and ongoing treatment (whether medication or lifestyle changes) is usually needed for lasting results
DINs are publicly available in the Health Canada Drug Product Database
A microtube-based wearable closed-loop minisystem for diabetes management
Discontinuing semaglutide after weight loss: strategy for weight maintenance and a possible new side effect
Collaborating with healthcare professionals to create a tailored treatment plan can significantly enhance your results
